AIxMed

Santa Clara, United States

AIxMed helps pathologists to digitize 3D cytology samples in minutes and extract clinical insights in seconds.

$2.8M raised

Apr 2023

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AIxMed raised?

AIxMed has raised $2.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2023.

Who are AIxMed's investors?

AIxMed's investors include Taiwania Capital Management Corporation.

Where is AIxMed headquartered?

AIxMed is headquartered in Santa Clara, United States.

What does AIxMed do?

AIxMed helps pathologists to digitize 3D cytology samples in minutes and extract clinical insights in seconds.

What stage is AIxMed at?

AIxMed is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 27, 2023.

MLA

"AIxMed — Funding & Investors." VCBacked, April 27, 2023, https://www.vcbacked.co/company/aixmed. Accessed July 2, 2026.

APA

VCBacked. (2023). AIxMed — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/aixmed

Wikipedia (cite web)

{{cite web |title=AIxMed — Funding & Investors |url=https://www.vcbacked.co/company/aixmed |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 27, 2023.